ID   NALM-24
AC   CVCL_3888
SY   NALM24
DR   BTO; BTO:0004935
DR   Cosmic; 996291
DR   Cosmic; 998701
DR   Cosmic; 999745
DR   Cosmic; 1037715
DR   JCRB; JCRB1826
DR   Wikidata; Q54907405
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1667895;
RX   PubMed=8139288;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10233379;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=14504097;
RX   PubMed=18599181;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=1667895; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1826
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX01 ! B262
OI   CVCL_5664 ! NALM-25
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1667895;
RA   Matsuo Y., Ariyasu T., Adachi T., Tsubota T., Minowada J.;
RT   "Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with
RT   bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia
RT   cell line (B262) established from a patient with acute lymphoblastic
RT   leukemia.";
RL   Hum. Cell 4:339-342(1991).
//
RX   PubMed=8139288; DOI=10.1016/0145-2126(94)90118-x;
RA   Sato S., Honma Y., Hozumi M., Hayashi Y., Matsuo Y., Shibata K.,
RA   Omura S., Hino K.-i., Tomoyasu S., Tsuruoka N.;
RT   "Effects of herbimycin A and its derivatives on growth and
RT   differentiation of Ph1-positive acute lymphoid leukemia cell lines.";
RL   Leuk. Res. 18:221-228(1994).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//
RX   PubMed=10233379; DOI=10.1111/j.1365-2141.1999.01284.x;
RA   Xu F., Taki T., Yang H.W., Hanada R., Hongo T., Ohnishi H.,
RA   Kobayashi M., Bessho F., Yanagisawa M., Hayashi Y.;
RT   "Tandem duplication of the FLT3 gene is found in acute lymphoblastic
RT   leukaemia as well as acute myeloid leukaemia but not in
RT   myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in
RT   children.";
RL   Br. J. Haematol. 105:155-162(1999).
//
RX   PubMed=10576511; DOI=10.1016/s0145-2126(99)00131-9;
RA   Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.;
RT   "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines.";
RL   Leuk. Res. 23:1055-1060(1999).
//
RX   PubMed=10637496; DOI=10.1038/sj.leu.2401604;
RA   Drexler H.G., Fombonne S., Matsuo Y., Hu Z.-B., Hamaguchi H.,
RA   Uphoff C.C.;
RT   "p53 alterations in human leukemia-lymphoma cell lines: in
RT   vitro artifact or prerequisite for cell immortalization?";
RL   Leukemia 14:198-206(2000).
//
RX   PubMed=14504097; DOI=10.1182/blood-2003-02-0418;
RA   Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R.,
RA   Tsuchida M., Sugita K., Ida K., Hayashi Y.;
RT   "FLT3 mutations in the activation loop of tyrosine kinase domain are
RT   frequently found in infant ALL with MLL rearrangements and pediatric
RT   ALL with hyperdiploidy.";
RL   Blood 103:1085-1088(2004).
//
RX   PubMed=18599181; DOI=10.1016/j.exphem.2008.04.011;
RA   Dida F., Li Y.-F., Iwao A., Deguchi T., Azuma E., Komada Y.;
RT   "Resistance to TRAIL-induced apoptosis caused by constitutional
RT   phosphorylation of Akt and PTEN in acute lymphoblastic leukemia
RT   cells.";
RL   Exp. Hematol. 36:1343-1353(2008).
//